Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PET Imaging in Patients With Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Very early researchLooking for participantsNCT06419348
What this trial is testing

99mTc-QULIC-5-P1 SPECT Imaging in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer StagePSMASPECT
First Affiliated Hospital of Chongqing Medical University 30
Testing effectiveness (Phase 2)Study completedNCT02815033
What this trial is testing

Imaging Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving Enzalutamide

Who this might be right for
Prostate Cancer Metastatic
The European Uro-Oncology Group 66
Testing effectiveness (Phase 2)Study completedNCT02814968
What this trial is testing

PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide

Who this might be right for
Prostate Cancer Metastatic
The European Uro-Oncology Group 66
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Early research (Phase 1)Study completedNCT02603965
What this trial is testing

Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate CancerStage III Prostate Cancer+1 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 25
Not applicableEnded earlyNCT06655064
What this trial is testing

Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Telix Pharmaceuticals (Innovations) Pty Limited 120
Very early researchActive Not RecruitingNCT04147494
What this trial is testing

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

Who this might be right for
Breast CarcinomaColon CarcinomaEsophageal Carcinoma+8 more
Jonsson Comprehensive Cancer Center 29
Not applicableStudy completedNCT06460454
What this trial is testing

PROnostic Interest of 18F-FDG PET/CT in Patients With Metastatic Castration-resistant Prostate Cancer (mCPRC) Progressing

Who this might be right for
Prostate Cancer
Central Hospital, Nancy, France 100
Testing effectiveness (Phase 2)Study completedNCT01304485
What this trial is testing

PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma

Who this might be right for
Prostate Cancer
Phoenix Molecular Imaging 2,000
Early research (Phase 1)Ended earlyNCT04927663
What this trial is testing

11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v8+5 more
Rahul Aggarwal 2
Large-scale testing (Phase 3)Study completedNCT03739684
What this trial is testing

Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Cancer Recurrent+1 more
Progenics Pharmaceuticals, Inc. 208
Testing effectiveness (Phase 2)Ended earlyNCT03463889
What this trial is testing

Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer

Who this might be right for
Thyroid Gland Carcinoma
University of California, San Francisco 12
Testing effectiveness (Phase 2)Study completedNCT02440308
What this trial is testing

68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer

Who this might be right for
Prostate Carcinoma
Stanford University 10
Testing effectiveness (Phase 2)Study completedNCT02384382
What this trial is testing

A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Carcinoma Metastatic to the BoneCastration Resistant Prostate Cancer
Pfizer 23
Large-scale testing (Phase 3)Not Yet RecruitingNCT06922903
What this trial is testing

Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.

Who this might be right for
Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd 240
Not applicableWithdrawnNCT02169063
What this trial is testing

Carbon-11 Acetate and Fluorine F 18 Sodium Fluoride PET as a Biomarker of Treatment Response in Patients With Hormone Resistant Metastatic Prostate Cancer

Who this might be right for
Hormone-resistant Prostate CancerRecurrent Prostate CancerStage IV Prostate Cancer
University of Washington
Early research (Phase 1)Study completedNCT02297386
What this trial is testing

[18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer

Who this might be right for
Prostate CancerLocalized Prostate Cancer
Memorial Sloan Kettering Cancer Center 3
Testing effectiveness (Phase 2)Looking for participantsNCT07285057
What this trial is testing

Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance

Who this might be right for
Prostatic NeoplasmsProstate CancerProstate Adenocarcinoma
Icahn School of Medicine at Mount Sinai 120
Testing effectiveness (Phase 2)Study completedNCT05008900
What this trial is testing

Timing of Post-prostatectomy PSMA Imaging

Who this might be right for
Prostate CancerProstatectomy
University Health Network, Toronto 4